Hypertension is highly prevalent in patients with rheumatoid arthritis (RA). In other populations, high sodium (Na + ) and low potassium (K +
) intake are associated with an increased risk of hypertension, and in animal models, a high salt intake exacerbated arthritis. Patients with RA have many comorbidities associated with salt sensitivity, but their salt intake and its relationship to blood pressure and inflammation is unknown. Using the Kawasaki formula, Na + and K + urinary excretion (reflecting intake) was estimated in 166 patients with RA and 92 controls, frequency matched for age, sex, and race. Inflammatory markers and disease activity were measured in RA patients. We tested the associations between blood pressure and Na + and K + excretion. Estimated 24-h Na + excretion was similarly high in both RA (median [IQR] 5.1 g, [3.9-6.6 g]) and controls (4.9 g, [4.0-6.5 g]), p = 0.9, despite higher rates of hypertension in RA (54 vs. 39%, p = 0.03). The Na + :K + excretion ratio was significantly higher in RA (2.0 [1.6-2.4]) vs. 1.7 [1.5-2.1]), p = 0.02] compared to controls. In RA, a lower K + excretion was inversely correlated with diastolic blood pressure (adjusted β = − 1.79, p = 0.04). There was no significant association between Na + or K + excretion and inflammatory markers. Despite a similar Na + excretion, patients with RA had higher rates of hypertension than controls, a finding compatible with increased salt sensitivity. Patients with RA had a lower Na + :K + excretion ratio than controls, and lower K + excretion was associated with higher diastolic blood pressure in RA.
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Hypertension is a modifiable risk factor for cardiovascular disease (CVD) and is highly prevalent among patients with RA compared with the general population [1] . The relative risk of CVD in RA patients with hypertension has been reported to be as high as 4.3 compared to those with normal blood pressure [2] . This increased risk of CVD mediated by hypertension in RA is particularly important because the risk of CVD is significantly higher in patients with RA compared to the general population [3, 4] . However, the underlying determinants of hypertension in patients with RA remain poorly defined [5] . High sodium (Na + ) intake is associated with both the risk of hypertension [6] and CVD mortality in the general population [7] [8] [9] . The 8th edition of the Dietary Guidelines for Americans, released by the U.S. Department of Health and Human Services in 2015 recommends a daily Na + intake of less than 2300 mg, compared to the average daily consumption by the American population of 3440 mg per day [10] . The current daily intake of Na + is also considered high by the American Heart Association which has made reduction of Na + intake in the general population a priority. The potential benefits of decreasing Na + intake continue to be debated although a study using data on sodium consumption from 66 countries estimated that 1.65 million deaths from cardiovascular events that occurred in 2010 alone were attributed to a Na + consumption above the reference level of 2.0 g per day [11] . The effects of reducing Na + intake in hypertension are clear; for example, a large multicenter cohort study among persons with and without hypertension showed that reducing Na + intake from 142 mmol/day to 107 mmol/day) for 30 days decreased systolic blood pressure (SBP) by 2.1 mmHg. A further decrease in Na + consumption to 65 mmol/day caused an additional reduction in SBP of 4.6 mmHg [6, 12] .
In addition to Na + intake, the intake of potassium (K + ) and the Na+/K+ ratio are also associated with the risk of developing CVD [7, 8] . In a large multicenter cross-sectional study, K + excretion was inversely associated with SBP [13] , and the combined effect of high Na + and low K + intake, measured by an increase in the Na + :K + excretion ratio, was associated with an increase in both SBP and DBP [13] .
Patients with RA have many clinical features associated with increased salt sensitivity including an increased prevalence of metabolic syndrome [14] , vascular stiffness [15] , insulin resistance [16] , central obesity [17] , and endothelial dysfunction [18, 19] . Furthermore, recent findings in animals implicate salt in autoimmunity and inflammation. A high salt diet augmented inflammation markedly in an experimental autoimmune encephalomyelitis (EAE) model of autoimmunity [20, 21] . In keeping with the concept that salt may exacerbate autoimmunity, a low salt diet ameliorated clinical and histological features of arthritis in a murine model [22] . However, little is known about the association between Na + and K + intake and blood pressure and the relationship between Na + intake and inflammation in patients with RA. Therefore, the aims of this study were (1) to examine the hypothesis that urinary Na + and K + excretion differed in patients with RA compared to control subjects, and (2) that urinary Na + and K + are related to blood pressure and markers of inflammation among RA patients.
Materials and methods
We studied 166 patients with RA and 92 controls without an autoimmune disease from a cross-sectional study performed at Vanderbilt University Medical Center from a cohort assembled to evaluate cardiovascular risk factors in RA [23, 24] . As described previously, patients with RA were recruited from rheumatology clinics in Nashville, TN, if they met the following inclusion criteria: fulfillment of the 1987 American College of Rheumatology classification criteria for RA [25] , age 18 years or older. Control subjects were volunteers without RA or inflammatory diseases. RA patients and control subjects were frequency matched on age, sex, and race.
RA patients and control subjects underwent a standard medical interview. Information about demographic characteristics, cardiovascular risk factors, disease duration, physical activity, medication use, and smoking habits was obtained by conducting a standardized interview, physical examination, and laboratory testing. Additional information was extracted from the electronic medical records. Height and weight were measured for body mass index (BMI) calculations and the presence of metabolic synd r o m e [ 1 4 ] u s i n g t h e m o d i f i e d Wo r l d H e a l t h Organization (WHO) criteria was determined [26] . Briefly, subjects were classified as having metabolic syndrome if they had insulin resistance (homeostasis model assessment index in the upper quartile), impaired fasting glucose (≥ 6.1 mmol/L), or diabetes with at least two of the following criteria: central obesity, dyslipidemia, and high blood pressure.
First morning midstream urine samples were collected and stored at a temperature of -80°C. For analysis, urine samples were thawed, centrifuged at 5000 rpm at 4°C for 5 min, and 100 μl of supernatant transferred to new Eppendorf tubes. The concentrations of urinary Na + and K + were measured by flame photometry using an EFOX 5053 Electrolyte Analyzer from Eppendorf®. The estimation of 24-h Na + and K + excretion was performed using the Kawasaki formula. The Kawasaki formula incorporates age, sex, height, weight, and the creatinine to Na + and K + concentrations of a spot urine sample [27, 28] . Additionally, RA patients had blood samples drawn after an overnightfasttomeasuremarkersofinflammation. C-reactive protein (CRP) was measured by the hospital laboratory or by enzymelinked immunosorbent assay (ELISA; Millipore, St. Charles, MO). Interleukin-6 (IL-6), vascular cell adhesion molecule-1 (VCAM-1), tumor necrosis factor (TNF-α), and insulin concentrations were measured by Multiplex ELISA (LincoPlex Multiplex Immunoassay kit, Millipore). The homeostasis model assessment (HOMA) index was used to determine insulin sensitivity ([fasting glucose (mmol/l) × fasting insulin (μU/ml)]/22.5), which was in turn used to determine insulin resistance, a diagnostic criteria for metabolic syndrome, which is associated with CVD in RA patients [14] .
Blood pressure was measured while patients were seated comfortably. The average of two measurements 5 min apart was considered as the blood pressure of study subjects. Hypertension was defined as the use of antihypertensive medications or SBP of ≥ 140 mmHg or DBP of ≥ 90 mmHg.
Informed consent was given by all patients and controls prior to data and sample collection. The study protocol was approved by the Vanderbilt University Medical Center's institutional review board.
Statistical analysis
Categorical and continuous variables were compared using Fisher's exact test and Wilcoxon's test, respectively. Spearman correlations were used to test the association between estimated 24-h Na + and K + excretion and blood pressure in RA patients and controls, and estimated 24-h Na + and K + excretion and inflammatory markers in RA patients. Multivariate linear regressions were modeled to assess the association between systolic and diastolic blood pressures and Na + andK + excretion and their ratio,adjusting for sex, age, and race. All statistical analyses were performed using Stata Version 13.0 (StataCorp, College Station, TX). Two-sided p values of < 0.05 were considered statistically significant.
Results
The characteristics of this cohort have been described previously [14, 23, 29] . Patients with RA (n = 166) and control subjects (n = 92) had similar median (interquartile range) age of 54 (45-63) vs. 53 (45-60) years, respectively, p = 0.43], were predominantly female (68.7 vs. 63.0%, p = 0.41) and Caucasian (88.6 vs. 84.8%, p = 0.44). Baseline characteristics that differed significantly among RA and control groups included insulin resistance (51.9 vs. 17.8%, p < 0.001), metabolic syndrome (37.1 vs. 21.8%, p = 0.02), smoking (23.5 vs. Table 1) .
The estimated median 24-h Na + excretion was 5.1 (IQR = 3.9-6.6) and 4.9 (4.0-6.5) g/day, (p = 0.9) and for K + was 2.5 (2.1-3.2) and 2.7 (2.2-3.8) g/day, p = 0.08 in RA patients and control subjects, respectively. The estimated urinary Na There was no significant association between the estimated Na + and K + excretion and SBP among RA patients; however, the estimated K + intake was inversely correlated with DBP [β coefficient (95% CI) = − 1.79 (− 3.46 to − 0.13), p value = 0.04] after adjustment for age, sex, and race (Table 2) . These results remained statistically significant after further adjustment for antihypertensive medications (β = − 1.70, p = 0.047), diuretic medications (β = − 1.74, p = 0.042), or NSAIDs (β = − 1.92, p = 0.025). Neither Na + nor K + intake was significantly associated with DAS28 or markers of inflammation, including VCAM-1, CRP, IL-6, IL-10, and TNF-α (all p values > 0.05) ( Table 3) .
Discussion
This study has several novel findings. First, the estimated 24-h Na + was high but did not differ in RA and controls despite a greater prevalence of hypertension in RA. Second, the mean estimated 24-h Na + :K + excretion ratio was higher among RA patients compared to control subjects. Third, among RA patients, the estimated 24-h K + excretion ratio was inversely associated with diastolic blood pressure (DBP).
The median estimated daily Na + intake was approximately 5500 mg in both groups and this is higher than the average intake of US adults [30] . This high intake has adverse cardiovascular effects and the American Heart Association and the Institute of Medicine recommend an intake of less than 1500 mg [31] and 2300 mg [32] of Na + , respectively, putting these patients at an increased risk for hypertension, cardiovascular events, and death.
We have previously reported in this cohort of RA patients that hypertension was more prevalent than in controls and this observation is concordant with the findings of others [5, 7, 33] . The finding that Na + excretion did not differ among patients with RA and controls is interesting because it suggests that patients with RA may represent a salt-sensitive population. Salt sensitivity is characterized by an increase in blood pressure caused by salt loading and a decrease of blood pressure following salt depletion. Salt sensitivity, which affects about half of the hypertensive population [34] , has been associated with metabolic syndrome [35] and endothelial dysfunction, [36] but its association with RA has yet to be studied.
A greater Na + :K + ratio is a risk factor of hypertension in the general population [13] , and was higher in RA patients compared to control subjects. The higher Na + :K + ratio likely reflects dietary intake. Also, 24-h K + excretion and DBP were inversely correlated. Similar findings were observed in the general population [13, 37] . The linear regression model indicated that for every 1-g increase in 24-h K + excretion, there was a 1.79 mmHg decrease in DBP. Despite being a modest decrease in DBP, previously published meta-analyses have shown that even small changes in diastolic blood pressure of 10 and even 5 mmHg can substantially modify the risk of cardiovascular death by as much as twofold [38, 39] . This is important because low K + intake is a modifiable risk factor of hypertension and it means that increasing K + intake may reduce the risk of hypertension among RA patients.
In addition to the vascular effects of Na + , pre-clinical studies have demonstrated that a high salt diet promotes inflammation and manifestations of autoimmune diseases [20, 21, 40] . Recent work in mice showed that high salt concentrations activate the immune system, particularly Th17 cells, resulting in production of IL-17 and other pro-inflammatory cytokines [20] . Moreover, clinical inflammation was markedly augmented by a high salt diet in an experimental autoimmune encephalomyelitis (EAE) model of autoimmunity [20, 21] . Additionally, in studies presented in the abstract [22] , a low salt diet ameliorated clinical and histological features of arthritis in a murine model. Also, recent epidemiologic studies suggest a relationship between high Na + intake and risk for RA [41, 42] . Despite these pre-clinical and epidemiologic findings, we did not find a statistically significant association between estimated Na + and K + excretion and inflammation markers among patients with RA. However, just as sensitivity of blood pressure to the same Na + intake varies, so too may the inflammatory response.
The study had some limitations. The cross-sectional design limits our ability to identify a temporal relationship between Na + and K + excretion and blood pressure. Second, the sample size was relatively small, and thus, we cannot exclude small changes or weak correlations between Na + and K + and blood pressure or inflammatory markers. Another potential limitation of our study is the use of a single urine collection, as the reported correlation Table 3 Association of disease activity score and inflammatory markers with estimated 24-h urinary Na Correlation analysis was performed using Spearman Correlation. p values of < 0.05 were considered statistically significant coefficient between the estimated sodium excretion using the Kawasaki formula and a 24-h collection is 0.71 [13] .
In conclusion, despite higher rates of hypertension in patients with RA, Na + excretion did not differ among patients with RA and control subjects; this is of interest as it might suggest that patients with RA represent a salt-sensitive population. This finding should be confirmed by future studies. Patients with RA had a lower Na + :K + excretion ratio than controls, and lower K + excretion was associated with higher diastolic blood pressure in RA. Future intervention studies are needed to fully understand the effects of Na + and K + intake on hypertension in this patient population. Compliance with ethical standards Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Institutes of Health. Informed consent was given by all patients and controls prior to data and sample collection. The study protocol was approved by the Vanderbilt University Medical Center's institutional review board.
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